Rick Powers
Impact in
- Immunology and Allergy top 10%
- Cell Adhesion Molecules Research
-
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
- CAR-T cell therapy research
Papers in
-
- Cell Adhesion Molecules Research 4
-
- Cancer Research and Treatments 1
- Co-authors
- Joann P. Palma (1 shared paper)Debra T. Chao (1 shared paper)Kurt Gish (2 shared papers)Kelly Foster (1 shared paper)Josue Samayoa (2 shared papers)Tamar Uziel (2 shared papers)Thomas P. McGonigal (2 shared papers)Lisa M. Durkin (1 shared paper)
- Journals
- European Journal of Cancer (1 paper)Molecular Cancer Therapeutics (1 paper)Cancer Research (1 paper)PubMed (2 papers)
- Partner nations
- United StatesAustralia
In The Last Decade
Rick Powers
5 papers receiving 379 citations
Peers
Comparison fields: 5 of 51
- Immunology and Allergy 87
- Oncology 164
- Radiology, Nuclear Medicine and Imaging 94
- Cancer Research 41
- Immunology 60
Countries citing papers authored by Rick Powers
This map shows the geographic impact of Rick Powers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rick Powers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rick Powers more than expected).
Fields of papers citing papers by Rick Powers
This network shows the impact of papers produced by Rick Powers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rick Powers. The network helps show where Rick Powers may publish in the future.
Co-authors
The 25 scholars most cited alongside Rick Powers, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 161 | |
| 2 | Preclinical evaluation of an anti-alpha5beta1 integrin antibody as a novel anti-angiogenic agent. | 2006 | 107 |
| 3 | 2004 | 73 | |
| 4 | E-selectin up-regulation allows for targeted drug delivery in prostate cancer. | 2003 | 59 |
| 5 | 2016 | 2 |
About Rick Powers
Rick Powers is a scholar working on Immunology and Allergy, Biotechnology, Genetics, Cancer Research and Molecular Biology, having authored 5 papers that have together received 402 indexed citations. Recurring topics across this work include Cell Adhesion Molecules Research (4 papers), Ubiquitin and proteasome pathways (2 papers), Chronic Lymphocytic Leukemia Research (1 paper), Protease and Inhibitor Mechanisms (1 paper), Cancer Cells and Metastasis (1 paper), Monoclonal and Polyclonal Antibodies Research (1 paper), Pancreatic and Hepatic Oncology Research (1 paper) and Cancer Research and Treatments (1 paper). The work is most often cited by research in Immunology and Allergy (87 citations), Oncology (164 citations), Radiology, Nuclear Medicine and Imaging (94 citations), Cancer Research (41 citations) and Immunology (60 citations). Rick Powers has collaborated with scholars based in United States and Australia. Frequent co-authors include Joann P. Palma, Debra T. Chao, Kurt Gish, Kelly Foster, Josue Samayoa, Tamar Uziel, Thomas P. McGonigal, Lisa M. Durkin, Dong Zhang and Eric D. Hsi. Their work appears in journals such as European Journal of Cancer, Molecular Cancer Therapeutics, Cancer Research and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.